Related Experiment Video
Updated: Mar 18, 2026
03:52
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
1.4K
Experimental models of sarcoidosis
Florence Jeny1, Yves Pacheco, Valerie Besnard
1aAP-HP, Hôpital Avicenne, Service de Pneumologie bUniversité Paris 13, EA2363, Sorbonne Paris Cité, Bobigny cUniversité Claude Bernard Lyon-1, Lyon dUniversité Pierre et Marie Curie, Sorbonne Universités, Paris, France.
Current Opinion in Pulmonary Medicine
|July 9, 2016
Summary
This review explores various models for studying granulomatous diseases, including sarcoidosis. While no single model perfectly replicates sarcoidosis, combining different models and a systems biology approach can advance understanding and preclinical drug evaluation.
Area of Science:
- Granulomatous diseases research
- Immunology
- Disease modeling
Background:
- Sarcoidosis etiology is complex, involving genetic, immune, and environmental factors.
- The disease's onset and varied presentations are not fully understood.
- A lack of reliable models hinders sarcoidosis research.
Purpose of the Study:
- To review existing models of granulomatous diseases.
- To challenge the assertion that no reliable sarcoidosis models are available.
- To explore how these models can advance sarcoidosis understanding.
Main Methods:
- Review of cellular and experimental animal models of granulomatous diseases.
- Analysis of data generated by various published models.
- Consideration of a systems biology approach.
Main Results:
- Numerous cellular and animal models exist for studying granulomas.
- While imperfect, current models provide valuable data for sarcoidosis research.
- A combination of models and clinical data offers a more complete picture.
Conclusions:
- Existing models, when carefully selected, contribute to understanding sarcoidosis.
- A systems biology approach is promising for integrating diverse data.
- Models are crucial for preclinical drug efficacy assessment in sarcoidosis.
